Cecilia Ruscitti, Laboratory of Immunophysiology, GIGA Institute, University of Liège, Liège 4000, Belgium; Faculty of Veterinary Medicine, University of Liège, Liège 4000, Belgium. E-mail: Cecilia.Ruscitti@uliege.be
Abstract
Aims: Severe COVID-19 is characterized by marked heterogeneity in lung pathology, including diffuse alveolar damage, inflammation, and fibrosis. However, how spatially organized cellular interactions contribute to these divergent pathological outcomes remains incompletely understood. We aimed to define the spatial organization of cellular microenvironments in severe COVID-19 lungs and identify niche-specific cellular interactions associated with distinct histopathological states.
Methods: We applied imaging-based single-cell spatial transcriptomics to post-mortem lung tissues from patients with severe COVID-19 and control subjects, enabling high-resolution mapping of cellular composition, spatial neighborhoods, and predicted ligand-receptor interactions within intact tissue architecture.
Results: Analysis of 76,973 cells identified 20 distinct cell populations and revealed marked heterogeneity between COVID-19 samples, corresponding to different histopathological states. Spatial niche analysis identified discrete macrophage-associated microenvironments. Fibrotic niches were enriched in CHI3L1/MMP9hi macrophages spatially associated with COL1A1+ fibroblasts and basal cells. Ligand-receptor inference predicted macrophage-derived TGF-β and galectin-3 signaling as drivers of pathogenic fibroblast activation and extracellular matrix remodeling. In contrast, alveolar niches contained SPP1hi macrophages exposed to epithelial-derived cues, including WNT ligands and GM-CSF, consistent with differentiation toward an alveolar macrophage-like state.
Conclusion: Severe COVID-19 lungs are organized into distinct spatial niches associated with divergent immunopathological trajectories. Imaging-based spatial transcriptomics provides a framework to link histopathological states with localized cellular interactions and macrophage-driven tissue remodeling programs.
Keywords
References
-
1. World Health Organization. COVID-19 cases|WHO COVID-19 dashboard [Internet]. Geneva: World Health Organization; 2023. Available from: https://data.who.int/dashboards/covid19/cases
-
3. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: A global literature survey. Crit Care. 2020;24(1):516.[DOI]
-
4. Azagew AW, Beko ZW, Ferede YM, Mekonnen HS, Abate HK, Mekonnen CK. Global prevalence of COVID-19-induced acute respiratory distress syndrome: Systematic review and meta-analysis. Syst Rev. 2023;12(1):212.[DOI]
-
6. Milross L, Hunter B, McDonald D, Merces G, Thomson A, Hilkens CMU, et al. Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19. EBioMedicine. 2024;99:104945.[DOI]
-
9. Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198-209.[DOI]
-
12. Rendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature. 2021;593(7860):564-569.[DOI]
-
14. Ganesan A, Moore AR, Zheng H, Toh J, Freedman M, Magis AT, et al. A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response. Immunity. 2025;58(8):2104-2119.e5.[DOI]
-
18. MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, et al. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021;6(13):e147413.[DOI]
-
22. Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970-979.[DOI]
-
31. Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19(11):3292-3320.[DOI]
-
32. Gu Z. Complex heatmap visualization. IMeta. 2022;1(3):e43.[DOI]
-
33. Browaeys R, Saelens W, Saeys Y. NicheNet: Modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159-162.[DOI]
-
40. Umekita K, Miyauchi S, Nomura H, Umeki K, Okayama A. Neutrophil-derived lactoferrin induces the inflammatory responses of rheumatoid arthritis synovial fibroblasts via Toll-like receptor 4. Clin Exp Rheumatol. 2019;37(5):834-841.[PubMed]
-
42. Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat Commun. 2020;11(1):6319.[DOI]
-
50. Zhu B, Wu Y, Huang S, Zhang R, Son YM, Li C, et al. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity. 2021;54(6):1200-1218.e9.[DOI]
-
54. Vannan A, Lyu R, Williams AL, Negretti NM, Mee ED, Hirsh J, et al. Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis. Nat Genet. 2025;57(3):647-658.[DOI]
-
55. Ruscitti C, Abinet J, Maréchal P, Meunier M, de Meeûs C, Vanneste D, et al. Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury. Sci Immunol. 2024;9(98):eado1227.[DOI]
-
56. Cong B, Dong X, Yang Z, Yu P, Chai Y, Liu J, et al. Single-cell spatiotemporal analysis of the lungs reveals Slamf9+ macrophages involved in viral clearance and inflammation resolution. Cell Discov. 2024;10:104.[DOI]
Copyright
© The Author(s) 2026. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Publisher’s Note
Share And Cite


